Allotera Therapeutics
PrivateLast Round
Series C
Extension
Jul 8, 2026
Total Funding Raised
$394M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allotera Therapeutics is a biotechnology company developing allogeneic, off-the-shelf CAR-T cell therapies for the treatment of hematological malignancies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allotera Therapeutics Comparables
Compare Allotera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioheng Therapeutics | 89% | |
| Beam Therapeutics | 83% | |
| AvenCell | 81% | |
Allotera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 8, 2026 | ||||
| Series C | Aug 27, 2025 | ||||
| Series B | Jul 15, 2021 | ||||
| Series A | Apr 13, 2020 |
Key People
Founding team and executive leadership
Allotera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYZZ Capital | Series B, Series C, Series A |
| Intermediate Capital Group | Series C, Series B |
| Fidelity Management & Research Company | Series B, Series C |
| BioGenerator Ventures | Series C Extension, Series A |
| Tybourne Capital Management | Series C, Series B |
| RiverVest Venture Partners | Series B, Series C, Series A |
| Abingworth | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
$35M round with participation from BioGenerator Ventures and LightChain Capital.
- Aug 27, 2025
$115M raised in early funding.
Allotera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allotera Therapeutics's valuation, stock price, and market status.